Global Hyperhidrosis Treatment Market Growth (Status and Outlook) 2023-2029

Global Hyperhidrosis Treatment Market Growth (Status and Outlook) 2023-2029

The global Hyperhidrosis Treatment market size is projected to grow from US$ 1273.7 million in 2022 to US$ 1873.1 million in 2029; it is expected to grow at a CAGR of 5.7% from 2023 to 2029.

Global top 5 players of hyperhidrosis treatment include Allergan (AbbVie), GlaxoSmithKline, Cynosure, Journey Medical Corporation and miraDry. As the largest player, Allergan (AbbVie) makes up over a quarter.

North America ranks first in terms of market size by region, making up around 35%, followed by Europe and Asia-Pacific.

Based on the product type, the hyperhidrosis treatment is primarily split into medications, surgical treatments and physiotherapy, etc. Among them, medical is the largest segment, with a share over 45%.

Hyperhidrosis treatment is mainly used for primary focal hyperhidrosis and secondary generalized hyperhidrosis, in which the former one dominates with a share over 60%.

In some people, the body’s mechanism for cooling itself is overactive — so overactive that they may sweat four or five times more than is necessary, or normal. When sweating is this extreme it can be embarrassing, uncomfortable, anxiety-inducing, dangerous, and disabling. It often disrupts all aspects of a person's life, from career choices and recreational activities to relationships, emotional well-being, and self-confidence. This kind of excessive sweating is a serious medical condition. It's called hyperhidrosis and it afflicts millions of people around the world (nearly 5% of the world's population). But, due to lack of awareness among sufferers and lack of education among medical professionals, most people are never diagnosed or relieved of their symptoms.

LPI (LP Information)' newest research report, the “Hyperhidrosis Treatment Industry Forecast” looks at past sales and reviews total world Hyperhidrosis Treatment sales in 2022, providing a comprehensive analysis by region and market sector of projected Hyperhidrosis Treatment sales for 2023 through 2029. With Hyperhidrosis Treatment sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Hyperhidrosis Treatment industry.

This Insight Report provides a comprehensive analysis of the global Hyperhidrosis Treatment landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Hyperhidrosis Treatment portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Hyperhidrosis Treatment market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Hyperhidrosis Treatment and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Hyperhidrosis Treatment.

This report presents a comprehensive overview, market shares, and growth opportunities of Hyperhidrosis Treatment market by product type, application, key players and key regions and countries.

Market Segmentation:

Segmentation by type
Medications
Surgical Treatments
Physiotherapy

Segmentation by application
Primary Focal Hyperhidrosis
Secondary Generalized Hyperhidrosis

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Allergan (AbbVie)
GlaxoSmithKline
Cynosure
Journey Medical Corporation
miraDry
Alma Lasers
Carpe
Duradry
Merz Ultherapy
Fotona
BTXA
Seaford Pharmaceuticals
Robugen GmbH

Please note: The report will take approximately 2 business days to prepare and deliver.